Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

147.50
-1.5500-1.04%
Post-market: 148.480.9760+0.66%18:26 EDT
Volume:4.44M
Turnover:655.81M
Market Cap:183.00B
PE:-56.41
High:149.44
Open:149.44
Low:147.19
Close:149.05
52wk High:157.29
52wk Low:108.46
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.85
T/O Rate:0.36%
Dividend:3.22
Dividend Rate:2.18%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.47
PE(LYR):21.76

Loading ...

Gilead Sciences Announces Dividend of R$ 0.2394442440 Per Unit for Brgildbdr 000

Reuters
·
Yesterday

Vir Biotechnology Names Aziz Sawaf as CFO Effective Oct. 5, 2026

Reuters
·
Yesterday

Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Yesterday

Moderna Inc. Stock Sheds 5.4%, Underperforms Peers

Dow Jones
·
Yesterday

Gilead put volume heavy and directionally bearish

TIPRANKS
·
Yesterday

Moderna Inc. Stock Climbs 3.1%, Outperforms Peers

Dow Jones
·
Sep 30

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-29

Reuters
·
Sep 29

SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board

Reuters
·
Sep 29

$20 Billion In Deals And Counting: Lilly's CEO Targets The "White Space" Of Science For Larger M&A

Options & Short Sell
·
Sep 29

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29

Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study

Reuters
·
Sep 28

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

Reuters
·
Sep 28

Health Rounds: Genetic Discovery Yields Clues Toward Reversal of Alzheimer's Brain Damage

Reuters
·
Sep 25

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 25

Moderna Inc. Stock Advances 7.0%, Outperforms Peers

Dow Jones
·
Sep 25

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

US Judge Steps Aside in Dispute over Hawaii Energy Settlement

Reuters
·
Sep 24

Stoke Therapeutics Names Solid Biosciences CEO Bo Cumbo to Board

Reuters
·
Sep 24

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 23

Moderna Inc. Stock Climbs 12.3%, Outperforms Peers

Dow Jones
·
Sep 22